IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vyne Therapeutics Inc (MNLOUSD)

Q1 2026 vs Q2 2026

Comparing institutional holders between quarters

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Staley Capital Advisers Inc
UNCHANGED
Shares51,472 from 51,472
Change0 (0%)
Value$33.5K (+$2.7K)
Filed 2026-08-11
Status
Staley Capital Advisers Inc
UNCHANGED51,47251,47200%$30.8K$33.5K+$2.7K2026-08-11
Showing 1 of 1 institutions